The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss FDA's Overreach on Compounded Peptides